Fuh Hwa 15+ Year Pharmaceuticals Bond ETF (00759B)

Overview

The Fuh Hwa 15+ Year Pharmaceuticals Bond ETF is a distinct exchange-traded fund (ETF) designed to offer investors an opportunity to engage in the credit market of the pharmaceutical sector through investment in long-term corporate bonds. This ETF focuses on bonds with maturities extending 15 years or more, primarily issued by companies within the global pharmaceutical industry. It is meticulously designed to track the performance of the Bloomberg Barclays US Corporate 15+ Year Pharmaceuticals Index, thus ensuring a diversified portfolio across various issuers in this sector. With more than 120 holdings and a significant volume of assets under management, it showcases a robust vehicle for investors aiming at income generation via regular quarterly distributions. Additionally, it provides exposure to the relatively stable credit characteristics inherent to the healthcare and pharmaceutical industry, making it an appealing option for those seeking sector-specific credit exposure. The ETF's strategic focus on long-duration bonds within the pharmaceutical sector not only caters to those interested in this specific industry but also offers insights into the broader sectoral trends, including shifts in interest rates or the credit outlook within the pharmaceuticals realm.

Products and Services

• Long-Term Corporate Bonds Investment

  This product focuses on investments in long-term corporate bonds specifically issued by companies in the global pharmaceutical sector. It aims to provide investors with a stable income generation opportunity through exposure to bonds that have maturities of 15 years or longer. This approach caters to individuals seeking long-term investment horizons within the pharmaceutical industry.

• Bloomberg Barclays US Corporate 15+ Year Pharmaceuticals Index Tracking

  The ETF is designed to track the performance of the Bloomberg Barclays US Corporate 15+ Year Pharmaceuticals Index. This ensures that the fund offers a diversified investment across a broad spectrum of issuers within the pharmaceutical sector. It reflects a strategic choice for investors looking to access a wide range of pharmaceutical companies through a single investment, thereby spreading risk and enhancing the potential for returns.

• Regular Quarterly Distributions

  This ETF provides regular quarterly distributions, catering to investors who are interested in generating a steady stream of income from their investment portfolios. The focus on long-term bonds within the stable pharmaceutical industry allows for regular income generation, appealing to those interested in sector-specific credit exposure and income-focused investment strategies.

• Exposure to Healthcare and Pharmaceutical Sector Credit Characteristics

  Investors are offered exposure to the unique credit characteristics of the healthcare and pharmaceutical sector, which is known for its relative stability. This feature is particularly attractive for investors who are seeking to diversify their portfolios by incorporating investments that are less susceptible to the volatile swings often seen in other sectors or in the broader equity market.